TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
133.59
-5.70 (-4.09%)
Feb 11, 2026, 3:54 PM EST - Market open
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.57 billion as of February 11, 2026. Its market cap has increased by 122.74% in one year.
Market Cap
4.57B
Enterprise Value
4.65B
1-Year Change
122.74%
Ranking
Category
Stock Price
$133.59
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $4.57B, an increase of 908.96%. That is a compound annual growth rate of 40.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.76B | 14.50% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Rad Laboratories | 8.09B |
| Bio-Rad Laboratories | 7.96B |
| Masimo | 7.20B |
| Glaukos | 6.49B |
| Bruker | 6.31B |
| iRhythm Holdings | 4.90B |
| LivaNova | 3.64B |
| Integer Holdings | 3.02B |